N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction
- PMID: 22348741
- DOI: 10.1111/j.1440-1843.2012.02153.x
N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction
Abstract
Background and objective: The aim of this study was to assess the performance of N-terminal proB-type natriuretic peptide (NT-proBNP) levels for the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease (COPD) and renal dysfunction.
Methods: NT-proBNP levels at admission were measured in consecutive patients admitted to two participating intensive care units with acute exacerbations of COPD. Left ventricular dysfunction was assessed on the basis of clinical and echocardiographic criteria. The performance of NT-proBNP levels was evaluated in patients with or without renal dysfunction.
Results: Among the 120 patients included in the study, 70 had impaired renal function, defined as a glomerular filtration rate of <90 mL/min/1.73 m(2). NT-proBNP levels were inversely correlated with glomerular filtration rate (Spearman's correlation coefficient = -0.457, P < 0.001). Overall, left ventricular dysfunction was diagnosed in 58 patients (48.3%). Median NT-proBNP levels were significantly higher in these patients, irrespective of whether their renal function was normal (3313 (interquartile range (IQR) 4603) vs 337 (IQR 695) pg/mL, P < 0.001) or impaired (5692 (IQR 10714) vs 887 (IQR 1165) pg/mL, P < 0.001). The areas under the receiver operating characteristic curves were 0.87 and 0.78, respectively. The threshold NT-proBNP value with the highest diagnostic accuracy was greater in the setting of renal dysfunction (2000 pg/mL; sensitivity 71%, specificity 82%, compared with 1000 pg/mL in patients with normal renal function; sensitivity 94%, specificity 82%). Multivariate analysis showed that left ventricular dysfunction and glomerular filtration rate were independently associated with elevated NT-proBNP levels.
Conclusions: NT-proBNP remains an accurate biomarker for the diagnosis of left ventricular dysfunction associated with acute exacerbations of COPD. Threshold values of NT-proBNP were higher in patients with impaired renal function than in those with normal renal function.
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.
Similar articles
-
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. doi: 10.1016/j.jacc.2005.08.051. Epub 2005 Dec 9. J Am Coll Cardiol. 2006. PMID: 16386670
-
B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.Acta Anaesthesiol Scand. 2006 Mar;50(3):340-7. doi: 10.1111/j.1399-6576.2006.00963.x. Acta Anaesthesiol Scand. 2006. PMID: 16480468
-
Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.Am J Respir Crit Care Med. 2006 Nov 1;174(9):990-6. doi: 10.1164/rccm.200603-380OC. Epub 2006 Jul 13. Am J Respir Crit Care Med. 2006. PMID: 16840745
-
[Interest of NT-proBNP in chronic heart failure follow-up].Ann Biol Clin (Paris). 2013 Nov;71:39-45. doi: 10.1684/abc.2013.0900. Ann Biol Clin (Paris). 2013. PMID: 24235327 Review. French.
-
B-type natriuretic peptides and echocardiographic measures of cardiac structure and function.JACC Cardiovasc Imaging. 2009 Feb;2(2):216-25. doi: 10.1016/j.jcmg.2008.12.006. JACC Cardiovasc Imaging. 2009. PMID: 19356559 Review.
Cited by
-
N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).Lung. 2018 Oct;196(5):583-590. doi: 10.1007/s00408-018-0137-3. Epub 2018 Jun 27. Lung. 2018. PMID: 29951921
-
NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study.Respir Res. 2012 Oct 29;13(1):97. doi: 10.1186/1465-9921-13-97. Respir Res. 2012. PMID: 23107284 Free PMC article.
-
B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.BMC Pulm Med. 2017 Jan 10;17(1):11. doi: 10.1186/s12890-016-0345-7. BMC Pulm Med. 2017. PMID: 28073350 Free PMC article.
-
Artificial intelligence in systematic reviews: promising when appropriately used.BMJ Open. 2023 Jul 7;13(7):e072254. doi: 10.1136/bmjopen-2023-072254. BMJ Open. 2023. PMID: 37419641 Free PMC article. Review.
-
Phenotyping COPD exacerbations using imaging and blood-based biomarkers.Int J Chron Obstruct Pulmon Dis. 2018 Jan 8;13:217-229. doi: 10.2147/COPD.S152484. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29386890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials